GeoVax Labs, Inc.
GOVX
$0.51
-$0.01-1.35%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 183.44% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 183.44% | -- | -- | -- | -- |
| Cost of Revenue | 10.57% | 22.04% | 6.55% | 6.55% | -9.38% |
| Gross Profit | 2.50% | -8.18% | 33.60% | 33.60% | 15.75% |
| SG&A Expenses | 42.01% | 9.64% | -24.86% | -24.86% | -25.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.94% | 19.69% | 0.52% | 0.52% | -13.20% |
| Operating Income | -7.05% | -8.46% | 31.92% | 31.92% | 18.07% |
| Income Before Tax | -6.04% | -8.83% | 30.84% | 30.84% | 14.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.04% | -8.83% | 30.84% | 30.84% | 14.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.04% | -8.83% | 30.84% | 30.84% | 14.57% |
| EBIT | -7.05% | -8.46% | 31.92% | 31.92% | 18.07% |
| EBITDA | -7.21% | -8.49% | 32.14% | 32.14% | 18.23% |
| EPS Basic | 82.47% | 77.65% | 80.89% | 80.89% | 47.43% |
| Normalized Basic EPS | 82.47% | 77.65% | 80.89% | 80.89% | 47.43% |
| EPS Diluted | 82.47% | 77.65% | 80.89% | 80.89% | 47.43% |
| Normalized Diluted EPS | 82.47% | 77.65% | 80.89% | 80.89% | 47.43% |
| Average Basic Shares Outstanding | 504.72% | 386.96% | 261.93% | 261.93% | 62.51% |
| Average Diluted Shares Outstanding | 504.72% | 386.96% | 261.93% | 261.93% | 62.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |